Detalhe da pesquisa
1.
Vemurafenib in patients with BRAF(V600) mutated metastatic melanoma: an open-label, multicentre, safety study.
Lancet Oncol
; 15(4): 436-44, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24582505
2.
Macitentan in Pulmonary Arterial Hypertension Associated with Connective Tissue Disease (CTD-PAH): Real-World Evidence from the Combined OPUS/OrPHeUS Dataset.
Cardiol Ther
; 13(2): 315-339, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451426
3.
Comparison of cardiac magnetic resonance imaging, functional and haemodynamic variables in pulmonary arterial hypertension: insights from REPAIR.
ERJ Open Res
; 10(1)2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38348238
4.
Efficacy and safety of bevacizumab in metastatic colorectal cancer: pooled analysis from seven randomized controlled trials.
Oncologist
; 18(9): 1004-12, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23881988
5.
Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertension.
ERJ Open Res
; 9(1)2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36687361
6.
Phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment for HER-2-positive locally recurrent or metastatic breast cancer.
Oncologist
; 17(4): 469-75, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22467666
7.
A randomized, double-blind, phase III study comparing two doses of erlotinib for second-line treatment of current smokers with advanced non-small-cell lung cancer (CurrentS).
Lung Cancer
; 99: 94-101, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27565921
8.
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Lancet
; 363(9426): 2022-31, 2004 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-15207952
9.
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.
Lancet
; 363(9426): 2049-51, 2004 Jun 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-15207957
10.
Vemurafenib in patients with BRAF(V600) mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study.
Eur J Cancer
; 50(3): 611-21, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24295639
11.
Randomized phase III trial of maintenance bevacizumab with or without pemetrexed after first-line induction with bevacizumab, cisplatin, and pemetrexed in advanced nonsquamous non-small-cell lung cancer: AVAPERL (MO22089).
J Clin Oncol
; 31(24): 3004-11, 2013 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-23835708
12.
Bevacizumab Combined With Weekly Paclitaxel, Pegylated Liposomal Doxorubicin, or Topotecan in Platinum-Resistant Recurrent Ovarian Cancer: Analysis by Chemotherapy Cohort of the Randomized Phase III AURELIA Trial.
J Clin Oncol
; 33(32): 3836-8, 2015 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26282651